Recombinant albumin-interferon alpha-2b fusion protein(Shanxi Kangbao Biological Product Co. Ltd.)

Primary objective: To evaluate the safety of a single administration of recombinant human serum albumin and interferon α-2b fusion protein for injection in healthy adult volunteers; To evaluate the tolerability of a single administration of recombinant human serum albumin and interferon α-2b fusion protein for injection in healthy adult volunteers; Secondary objective: To evaluate the pharmacokinetic (PK) characteristics of a single administration of recombinant human serum albumin and interferon α-2b fusion protein for injection in healthy adult volunteers. To evaluate the pharmacodynamic (PD) characteristics of a single administration of recombinant human serum albumin and interferon α-2b fusion protein for injection in healthy adult volunteers. To evaluate the immunogenicity characteristics of a single administration of recombinant human serum albumin and interferon α-2b fusion protein for injection in healthy adult volunteers.